Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Demicheli

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Breast Cancer Research and Treatment|January 1, 1996
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyM Terenziani, R Demicheli, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic processR Demicheli, R Miceli, A Moliterni, et al.
Breast Cancer Research and Treatment|January 24, 2002
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancerG Mariani, P Tagliabue, P Zucchinelli, et al.
Breast Cancer Research and Treatment|October 29, 1997
Computer simulation of a breast cancer metastasis modelM W Retsky, R Demicheli, D E Swartzendruber, et al.
Breast Cancer Research and Treatment|July 1, 1997
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patientsM Zambetti, R Demicheli, D De Candis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical resultsP F Conte, G Gardin, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Breast Cancer Research and Treatment|January 1, 1996
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyM Terenziani, R Demicheli, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic processR Demicheli, R Miceli, A Moliterni, et al.
Breast Cancer Research and Treatment|January 24, 2002
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancerG Mariani, P Tagliabue, P Zucchinelli, et al.
Breast Cancer Research and Treatment|October 29, 1997
Computer simulation of a breast cancer metastasis modelM W Retsky, R Demicheli, D E Swartzendruber, et al.
Breast Cancer Research and Treatment|July 1, 1997
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patientsM Zambetti, R Demicheli, D De Candis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical resultsP F Conte, G Gardin, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 5